Class: Human Milk Oligosaccharide (HMO)
Format: Powder
MyOli® 5HMOMIX™
2'-FL is the most abundant HMO in breast milk and is most researched together with LNT, 3-FL, 6’-SL and 3’-SL.
Product features, details and benefits
- Health benefits and studies
All HMOs in the MyOli™ 5 HMO Mix have been reported to reduce growth of several common harmful bacteria. The single ingredients of the new HMO-Mix support a natural gut microbiome by nourishing beneficial gut bacteria such as bifidobacteria, lactobacilli and bacteroides.1, 2 Furthermore, 2′-FL, 3-FL and 6′-SL support intestinal motility and intestinal epithelial cell maturation.3, 4 Fucosylated and sialylated HMOs also exert immune benefits. They may help support normal levels of cytokines and immune markers in infants5 and balance immune responses.6 Specifically 3′-SL and 6′-SL are suggested to positively support brain development in infants by affecting cognition and regulation of neurons.7
We have successfully established the industrial production of the five most important human milk oligosaccharides (HMOs) and thus launched its next product generation, the MyOli® 5HMOMIX™, which contains both neutral and acidic HMOs.
This product contains microbials. While microbial products are safe to use in consumer applications, they must be handled correctly in production environments to ensure that workers do not inhale organic dust and bioaerosols.
Please follow the precautionary handling recommendations below:
- Avoid breathing dust/fume/gas/mist/vapors/spray
- Avoid contact with eyes, skin, or clothing
- In case of inadequate ventilation wear respiratory protection
- IF INHALED: Remove person to fresh air and keep comfortable for breathing
- Store in a dry place. Store in a closed container
- Dispose of contents/containers in accordance with local regulations
For recommendations on how to safely handle the microbial product, please visit the guide.
Get in touch
Fill out the form below and one of our experts will contact you shortly.
One more step…
To complete the get in touch form or sign up, please click on the button below to enable cookies.
1 Bode, Lars. “Human milk oligosaccharides: prebiotics and beyond.” Nutrition reviews 67.suppl_2 (2009): S183-S191.
2 Gotoh, Aina, et al. “Sharing of human milk oligosaccharides degradants within bifidobacterial communities in faecal cultures supplemented with Bifidobacterium bifidum.” Scientific reports 8.1 (2018): 1-14.
3 Özcan, Ezgi, and David A. Sela. “Inefficient metabolism of the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose shifts Bifidobacterium longum subsp. infantis physiology.” Frontiers in Nutrition 5 (2018): 46.
4 Craft, Kelly M., and Steven D. Townsend. “The human milk glycome as a defense against infectious diseases: rationale, challenges, and opportunities.” ACS infectious diseases 4.2 (2018): 77-83.
5 El-Hawiet, Amr, Elena N. Kitova, and John S. Klassen. “Recognition of human milk oligosaccharides by bacterial exotoxins.” Glycobiology 25.8 (2015): 845-854.
6 Lin, Ann E., et al. “Human milk oligosaccharides inhibit growth of group B Streptococcus.” Journal of Biological Chemistry 292.27 (2017): 11243-11249.
Disclaimer
This content is intended exclusively for business-to-business purposes for a professional audience only and is not intended to target consumers.